{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Medication+Group&page=20", "query": { "intervention": "Medication Group", "page": 20 }, "page_size": 10 }, "pagination": { "page": 20, "page_size": 10, "total_count": 6190, "total_pages": 619, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Medication+Group&page=21&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Medication+Group&page=19&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-07T12:13:13.901Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT07795567", "title": "A Study Comparing Ivermectin Cream 1%, Soolantra™ Cream 1%, PrROSIVER® Cream1% to Placebo Control in the Treatment of Moderate to Severe Facial Rosacea.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Rosacea" ], "interventions": [ { "name": "Ivermectin Cream 1%", "type": "DRUG" }, { "name": "Soolantra™ Cream 1%", "type": "DRUG" }, { "name": "PrRosiver® Cream 1%", "type": "DRUG" }, { "name": "Placebo Control", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sun Pharmaceutical Industries, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 865, "start_date": "2025-12-09", "completion_date": "2026-06-24", "has_results": false, "last_update_posted_date": "2026-08-31", "last_synced_at": "2026-11-07T12:13:13.901Z", "location_count": 1, "location_summary": "Hawthorne, New York", "locations": [ { "city": "Hawthorne", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT07795567" }, { "nct_id": "NCT05108870", "title": "TheraT® Vectors (Vaccines) Combined With Chemotherapy to Treat HPV16 Head and Neck Cancers", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Human Papilloma Virus", "HPV", "HPV Positive Oropharyngeal Squamous Cell Carcinoma", "Head and Neck Cancer" ], "interventions": [ { "name": "HB-201", "type": "DRUG" }, { "name": "HB-202", "type": "DRUG" }, { "name": "Carboplatin", "type": "DRUG" }, { "name": "Paclitaxel", "type": "DRUG" }, { "name": "Transoral Robotic Surgery", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "PROCEDURE" ], "sponsor": "University of Chicago", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 35, "start_date": "2022-08-22", "completion_date": "2027-01-01", "has_results": false, "last_update_posted_date": "2026-04-24", "last_synced_at": "2026-11-07T12:13:13.901Z", "location_count": 1, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT05108870" }, { "nct_id": "NCT01156480", "title": "Anti-inflammatory Treatment at the Onset of Necrotizing Enterocolitis (NEC) in Preterm Infants", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Necrotizing Enterocolitis" ], "interventions": [ { "name": "hydrocortisone", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Endeavor Health", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "0 Days", "maximum_age": "6 Months", "sex": "ALL", "summary": "0 Days to 6 Months" }, "enrollment_count": 2, "start_date": "2009-09", "completion_date": "2012-11", "has_results": true, "last_update_posted_date": "2020-09-09", "last_synced_at": "2026-11-07T12:13:13.901Z", "location_count": 2, "location_summary": "Chicago, Illinois • Evanston, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" }, { "city": "Evanston", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT01156480" }, { "nct_id": "NCT00709280", "title": "Infant Study of Inhaled Saline in Cystic Fibrosis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Cystic Fibrosis" ], "interventions": [ { "name": "7% Hypertonic Saline (HS)", "type": "DRUG" }, { "name": "0.9% Isotonic Saline (IS)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "CF Therapeutics Development Network Coordinating Center", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": "4 Months", "maximum_age": "59 Months", "sex": "ALL", "summary": "4 Months to 59 Months" }, "enrollment_count": 321, "start_date": "2009-04", "completion_date": "2011-11", "has_results": false, "last_update_posted_date": "2013-02-12", "last_synced_at": "2026-11-07T12:13:13.901Z", "location_count": 28, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Palo Alto, California + 24 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Palo Alto", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT00709280" }, { "nct_id": "NCT05992896", "title": "A Study of Loco-Regional Liposomal Bupivacaine Injection", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Peripheral Arterial Disease" ], "interventions": [ { "name": "Bupivacaine liposome", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 3, "start_date": "2023-09-26", "completion_date": "2025-06-30", "has_results": true, "last_update_posted_date": "2026-05-29", "last_synced_at": "2026-11-07T12:13:13.901Z", "location_count": 1, "location_summary": "Eau Claire, Wisconsin", "locations": [ { "city": "Eau Claire", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT05992896" }, { "nct_id": "NCT02505542", "title": "Study to Evaluate Maintenance of Sustained Remission of axSpA With CZP Compared to Placebo", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Axial Spondyloarthrithis", "Ankylosing Spondylitis" ], "interventions": [ { "name": "Certolizumab Pegol", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "OTHER" ], "sponsor": "UCB BIOSCIENCES GmbH", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "18 Years to 45 Years" }, "enrollment_count": 736, "start_date": "2015-07", "completion_date": "2019-04", "has_results": true, "last_update_posted_date": "2020-12-17", "last_synced_at": "2026-11-07T12:13:13.901Z", "location_count": 16, "location_summary": "Glendale, Arizona • Mesa, Arizona • Phoenix, Arizona + 13 more", "locations": [ { "city": "Glendale", "state": "Arizona" }, { "city": "Mesa", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Sun City", "state": "Arizona" }, { "city": "Palm Desert", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02505542" }, { "nct_id": "NCT05802173", "title": "Study of TDM-105795 Following Topical Administration in Male Subjects With Androgenetic Alopecia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Alopecia, Androgenetic" ], "interventions": [ { "name": "TDM-105795, 0.0025%", "type": "DRUG" }, { "name": "TDM-105795, 0.02%", "type": "DRUG" }, { "name": "TDM-105795 topical vehicle solution", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Technoderma Medicines Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "MALE", "summary": "18 Years to 55 Years · Male only" }, "enrollment_count": 71, "start_date": "2023-03-06", "completion_date": "2024-01-29", "has_results": true, "last_update_posted_date": "2025-11-12", "last_synced_at": "2026-11-07T12:13:13.901Z", "location_count": 13, "location_summary": "North Little Rock, Arkansas • Rolling Meadows, Illinois • Plainfield, Indiana + 10 more", "locations": [ { "city": "North Little Rock", "state": "Arkansas" }, { "city": "Rolling Meadows", "state": "Illinois" }, { "city": "Plainfield", "state": "Indiana" }, { "city": "Baton Rouge", "state": "Louisiana" }, { "city": "New Orleans", "state": "Louisiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT05802173" }, { "nct_id": "NCT04486066", "title": "An Evaluation of MBSR and CBT for Veterans With Chronic Pain", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Chronic Pain", "Pain" ], "interventions": [ { "name": "Mindfulness-Based Stress Reduction", "type": "BEHAVIORAL" }, { "name": "Cognitive Behavioral Therapy for Chronic Pain", "type": "BEHAVIORAL" }, { "name": "Usual Care", "type": "OTHER" } ], "intervention_types": [ "BEHAVIORAL", "OTHER" ], "sponsor": "VA Office of Research and Development", "sponsor_class": "FED", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 217, "start_date": "2021-01-27", "completion_date": "2024-09-30", "has_results": true, "last_update_posted_date": "2025-06-25", "last_synced_at": "2026-11-07T12:13:13.901Z", "location_count": 1, "location_summary": "Seattle, Washington", "locations": [ { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT04486066" }, { "nct_id": "NCT04451954", "title": "Study of Recombinant Influenza Vaccine Containing Different H3 Antigens Without or With Adjuvant in Healthy Adult Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Influenza Immunisation", "Healthy Volunteers" ], "interventions": [ { "name": "Quadrivalent RIV with H3 strain 1", "type": "BIOLOGICAL" }, { "name": "Quadrivalent RIV with H3 strain 1 and adjuvant", "type": "BIOLOGICAL" }, { "name": "Quadrivalent RIV with H3 strain 2", "type": "BIOLOGICAL" }, { "name": "Quadrivalent RIV with H3 strain 2 and adjuvant", "type": "BIOLOGICAL" }, { "name": "Quadrivalent RIV with 2018-2019 NH H3 strain", "type": "BIOLOGICAL" }, { "name": "Quadrivalent RIV with 2018-2019 NH H3 strain and adjuvant", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Sanofi Pasteur, a Sanofi Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 210, "start_date": "2020-07-02", "completion_date": "2021-09-20", "has_results": false, "last_update_posted_date": "2025-09-17", "last_synced_at": "2026-11-07T12:13:13.901Z", "location_count": 5, "location_summary": "San Diego, California • Melbourne, Florida • Orlando, Florida + 2 more", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "Melbourne", "state": "Florida" }, { "city": "Orlando", "state": "Florida" }, { "city": "Peoria", "state": "Illinois" }, { "city": "Rockville", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT04451954" }, { "nct_id": "NCT04109222", "title": "Collection of Serum Samples From Children and Older Adults Receiving the 2019-2020 Formulations of Fluzone® Quadrivalent and Fluzone® High-Dose Influenza Vaccines, Respectively", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Influenza" ], "interventions": [ { "name": "Fluzone Quadrivalent vaccine, no preservative (0.5-mL), 2019-2020 formulation", "type": "BIOLOGICAL" }, { "name": "Fluzone High-Dose vaccine, 2019-2020 formulation", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Sanofi Pasteur, a Sanofi Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "6 Months", "maximum_age": "83 Years", "sex": "ALL", "summary": "6 Months to 83 Years" }, "enrollment_count": 90, "start_date": "2019-09-30", "completion_date": "2019-12-10", "has_results": true, "last_update_posted_date": "2025-09-12", "last_synced_at": "2026-11-07T12:13:13.901Z", "location_count": 2, "location_summary": "Bardstown, Kentucky • Salt Lake City, Utah", "locations": [ { "city": "Bardstown", "state": "Kentucky" }, { "city": "Salt Lake City", "state": "Utah" } ], "official_url": "https://clinicaltrials.gov/study/NCT04109222" } ] }